FDA Inspection 609802 — GlaxoSmithKline LLC
The FDA completed an inspection of GlaxoSmithKline LLC on August 24, 2009 in Zebulon, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 24, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zebulon, NC (United States)